Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 42, Issue 5, 2013, Pages 1309-1321

  Mendoza Milla, Criselda ^a   Jiménez, Ana Valero ^a   Rangel, Claudia ^b   Lozano, Alfredo ^a   Morales, Violeta ^a   Becerril, Carina ^a   Chavira, Roberto ^c   Ruiz, Víctor ^a   Barrera, Lourdes ^a   Montanõ, Martha ^a   Pardo, Annie ^d   Selman, Moisés ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 9; CHAPERONIN 60; CYCLIN DEPENDENT KINASE INHIBITOR; DEATH RECEPTOR 5; HEAT SHOCK PROTEIN 70; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; LIVIN; P21 ACTIVATED KINASE 1; PRASTERONE; PRASTERONE SULFATE; PROTEIN BAX; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGING; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHEMOLUMINESCENCE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOKING CESSATION; UPREGULATION; WESTERN BLOTTING;

AGED; APOPTOSIS; BRONCHOALVEOLAR LAVAGE; CASE-CONTROL STUDIES; CASPASE 9; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84887314574     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00027412     Document Type: Article

References (46)

1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949-1961.
2. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement. Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
3. Olson AL, Swigris JJ, Lezotte DC, et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007; 176: 277-284.
4. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816.
5. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009; 10: 45-61.
6. Selman M, Rojas M, Mora AL, et al. Aging and interstitial lung diseases: unraveling an old forgotten player in the pathogenesis of lung fibrosis. Semin Respir Crit Care Med 2010; 31: 607-617.
7. Makrantonaki E, Schonknecht P, Hossini AM, et al. Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol 2010; 45: 801-813.
8. Buford TW, Willoughby DS. Impact of DHEA(S) and cortisol on immune function in aging: A brief review. Appl Physiol Nutr Metab 2008; 33: 429-433.
9. Carroll D, Phillips AC, Lord JM, et al. Cortisol, dehydroepiandrosterone sulphate, their ratio and hypertension: evidence of associations in male veterans from the Vietnam experience study. J Hum Hypertens 2011; 25: 418-424.
10. Forsblad-d'Elia H, Carlsten H, Labrie F, et al. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009; 94: 2044-2051.
11. Fukui M, Kitagawa Y, Ose H, et al. Role of endogenous androgen against insulin resistance and athero-sclerosis in men with type 2 diabetes. Curr Diabetes Rev 2007; 3: 25-31.
12. Barrera L, Mendoza F, Zuniga J, et al. Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 2008; 177: 44-55.
13. Ramos C, Montano M, Becerril C, et al. Acidic fibroblast growth factor decreases a-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2006; 291: L871-L879.
14. Ho HY, Cheng ML, Chiu HY, et al. Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function. Int J Oncol 2008; 33: 969-977.
15. Jiang Y, Miyazaki T, Honda A, et al. Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone. J Gastroenterol 2005; 40: 490-497.
16. Lopez-Marure R, Contreras PG, Dillon JS. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur J Pharmacol 2011; 660: 268-274.
17. Reuter KC, Loitsch SM, Dignass AU, et al. Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro. PLoS One 2012; 7: e29756.
18. Huang SK, White ES, Wettlaufer SH, et al. Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J 2009; 23: 4317-4326.
19. Yasuda Y, Saito M, Yamamura T, et al. Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A2a adenosine receptors. J Gastroenterol 2009; 44: 56-65.
20. Ray RB, Raychoudhuri A, Steele R, et al. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res 2010; 70: 1925-1931.
21. Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005; 2: e251.
22. Montes E, Ruiz V, Checa M, et al. Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis. Eur Respir J 2011; 39: 141-148.
23. Hammer S, To KK, Yoo YG, et al. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells. Cell Cycle 2007; 6: 1919-1926.
24. Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051-13056.
25. Genazzani AD, Lanzoni C, Genazzani AR. Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging 2007; 24: 173-185.
26. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997; 278: 419-424.
27. Sumida Y, Yonei Y, Kanemasa K, et al. Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. Hepatol Res 2010; 40: 901-910.
28. Ohlsson C, Labrie F, Barrett-Connor E, et al. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J Clin Endocrinol Metab 2010; 95: 4406-4414.
29. Weiss EP, Villareal DT, Fontana L, et al. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY) 2011; 3: 533-542.
30. Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 2008; 47: 484-492.
31. Lee KS, Oh KY, Kim BC. Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. J Dermatol Sci 2000; 23: 103-110.
32. Iwasaki T, Mukasa K, Yoneda M, et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. Am J Physiol Endocrinol Metab 2005; 288: E1222-E1228.
33. Alexaki VI, Charalampopoulos I, Panayotopoulou M, et al. Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. Exp Cell Res 2009; 315: 2275-2283.
34. Lazaridis I, Charalampopoulos I, Alexaki VI, et al. Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol 2011; 9: e1001051.
35. Paulin R, Meloche J, Jacob MH, et al. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2011; 301: H1798-H1809.
36. Webb SJ, Geoghegan TE, Prough RA, et al. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 2006; 38: 89-116.
37. Horowitz JC, Lee DY, Waghray M, et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-b1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 2004; 279: 1359-1367.
38. Horowitz JC, Rogers DS, Sharma V, et al. Combinatorial activation of FAK and AKT by transforming growth factor-b1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007; 19: 761-771.
39. Bao Q, Shi Y. Apoptosome: A platform for the activation of initiator caspases. Cell Death Differ 2007; 14: 56-65.
40. Lavrik IN. Systems biology of apoptosis signaling networks. Curr Opin Biotechnol 2010; 21: 551-555.
41. Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011; 351: 41-58.
42. Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 2004; 69: 279-289.
43. Bonnet S, Paulin R, Sutendra G, et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-b/NFAT axis. Circulation 2009; 120: 1231-1240.
44. Gayosso V, Montano LF, Lopez-Marure R. DHEA-induced antiproliferative effect in MCF-7 cells is androgen- and estrogen receptor-independent. Cancer J 2006; 12: 160-165.
45. Ashida K, Goto K, Zhao Y, et al. Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase. Biochim Biophys Acta 2005; 1728: 84-94.
46. Homma N, Nagaoka T, Karoor V, et al. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 2008; 295: L71-L78.